NORTHROP GRUMMAN CORP /DE/ (NOC) SEC Filings

Northrop Grumman director Marianne Catherine Brown acquired 96 shares of common stock on September 30, 2026, deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan. The transaction lists a reported per-share amount of $483.48. Her reported holdings after the transaction were 11,706 shares, including dividends held in the stock unit account.

NORTHROP GRUMMAN CORP (symbol: NOC) is the issuer of record for a Form 4 filing submitted to the SEC.

Northrop Grumman Corporation (NOC) approved a one-time, performance-based equity grant for Kathy J. Warden, Chair, Chief Executive Officer and President. The grant consists of 35,910 Market Stock Units (MSUs), with an earn-out range from 0% to 150% of target based on the company’s absolute stock price performance over a performance period ending December 31, 2031. A 0% payout applies if the stock price depreciates by more than 25%, and a 150% payout applies if it appreciates by 50% or more. To earn the target award, the stock price must appreciate by at least 10%. The award is generally conditioned on Ms. Warden’s continued service through the performance period and is governed by the applicable Market Stock Units Grant Agreement.

Capital International Investors, a division of Capital Research and Management Company and its affiliated investment management entities, reported beneficial ownership of 6,044,489 shares of Northrop Grumman Corp. common stock. This represents 4.3% of the 142,033,476 shares believed to be outstanding as of the report.

Capital International Investors has sole voting power over 5,851,522 shares and sole dispositive power over 6,044,489 shares, with no shared voting or dispositive power. The filing indicates ownership of 5 percent or less of this class of securities.

Northrop Grumman Corp. director Mark A III Welsh reported selling a total of 95 shares of common stock on August 3, 2026. The 10 open‑market transactions were executed at weighted‑average prices including $544.53 and $554.14 per share, pursuant to a pre‑arranged Rule 10b5‑1 trading plan adopted on August 23, 2025.

A shareholder of Northrop Grumman Corp. filed to sell common stock on or after 07/22/2026 through Merrill Lynch on the NYSE. The planned sale covers multiple blocks of common stock originally received as equity compensation from grants dated between 2015 and 2026, including an entry for 4,304 units tied to a May 20, 2026 grant.

Northrop Grumman reported Q2 2026 sales of $10.9 billion, up 5% year over year, with net earnings of $1.09 billion and diluted EPS of $7.68, down 6% mainly because 2025 included a $231 million gain on the sale of its training services business and a larger pension FAS/CAS adjustment.

For the first six months, sales rose 5% to $20.8 billion, net earnings grew 19% to $2.0 billion, and diluted EPS increased 21% to $13.83, helped by stronger segment operating income and a sharply lower effective tax rate of 10.4% versus 17.5%, driven by research tax credits and remeasurement of uncertain tax positions.

Aeronautics led growth, with sales up 15% year to date and operating income rebounding as prior‑year B‑21 loss charges did not recur, though the B‑21 LRIP phase still carries about $2.0 billion in cumulative losses and a $1.0 billion remaining loss accrual. Defense Systems grew sales organically but margins compressed on unfavorable cost estimate changes for missile programs, including SiAW. Mission Systems expanded margins above 15%, while Space Systems margins were pressured by cost growth on solid rocket motor work.

Backlog reached $104.7 billion, with 35% expected to convert to revenue within 12 months. Operating cash flow was a use of $376 million year to date as working capital increased, while the company invested $469 million in capital expenditures, paid $684 million in dividends after a 7% per‑share increase, repurchased $68 million of stock and reduced long‑term debt by $527 million.

Northrop Grumman reported solid top-line growth in second quarter 2026 while earnings softened year-over-year. Sales rose 5 percent to $10.9 billion, driven by increases across all four segments, led by 13 percent growth at Aeronautics Systems. Net earnings were $1.1 billion and diluted EPS were $7.68, down 7 percent and 6 percent, respectively, largely because the prior-year period included a $231 million gain from the divestiture of the training services business. Net awards reached $20.0 billion, lifting total backlog to a record $104.7 billion.

Operating income declined 23 percent to $1.1 billion and the operating margin fell to 10.1 percent, reflecting the absence of the prior divestiture gain and lower segment operating income, particularly at Defense Systems and Space Systems, where unfavorable EAC adjustments on missile and space programs weighed on margins. Cash generation improved meaningfully: net cash provided by operating activities increased 47 percent to $1,280 million and adjusted free cash flow rose 54 percent to $978 million. On the back of stronger demand and record backlog, the company raised its 2026 sales guidance to $43.75–$44.25 billion and MTM-adjusted EPS guidance to $28.60–$29.10, while reaffirming operating income and adjusted free cash flow targets.

Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director Marianne Catherine Brown received an award of 91 shares of common stock, valued at $509.31 per share, as a compensation grant. The shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, she holds 11,558 shares of common stock, including dividends, in the stock unit account pursuant to the plan, reflecting a routine, non–open-market equity compensation event.